NCT01934699

Brief Summary

The investigators will compare myocard vitality diagnostics using 2D-Strain echography and MRI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 4, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

September 23, 2015

Status Verified

September 1, 2015

Enrollment Period

4.9 years

First QC Date

August 29, 2013

Last Update Submit

September 22, 2015

Conditions

Keywords

Coronary stenosisAngina pectorisLeft ventricular wall motion abnormalities2D-Strain

Outcome Measures

Primary Outcomes (1)

  • State of health score

    State of health score will be determinated by all patients for the evaluation of clinical outcomes (using the standardized questionnaire on state of health (SF-36))6 months after clinical diagnostics.

    6 month after diagnistics

Secondary Outcomes (3)

  • Left ventricular function (ejection function)

    6 month after diagnistics

  • End-diastolic and end-systolic volume.

    6 month after diagnostics

  • Capture of Major Adverse Cardiac and Cerebrovascular Events(MACCE)

    18 month after diagnostics

Study Arms (2)

MRI-Arm

ACTIVE COMPARATOR

Myocardial vitality determination based on MRI diagnostics.

Device: MRI scanner

Echo-Arm

EXPERIMENTAL

Myocardial vitality determination using echocardiography in combination with 2D-Strain Analysis.

Device: Cardiac ultrasound

Interventions

Patient will get echocardiographic examination during coronary angiography. 2D-Strain Analysis will be performed based on data of these echocardiographic examination. Only when vitality in the contraction impaired segments will be established based on 2D-Strain Analysis, PCI will be performed.

Echo-Arm

Coronary angiography on patient will be canceled. Patients will get viability assessment using MRI within the next 7 days. When vitality will be established with MRI, patient will get PCI.

MRI-Arm

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Typical angina pectoris symptoms
  • Echocardiographic determination of regional motion disfunction of left ventricular wall
  • Establishment of needly treatment of stenosis related to motion disorder based on coronar angiography.
  • Feasibility of MRI-Examination.
  • Patients which are legally competent and which are mentally able to understand the study staff
  • Patients give their written consent

You may not qualify if:

  • Allergy against contrast agent
  • Patients with limited renal function(GFR \< 60 ml/min)
  • Acute or instable angina pectoris

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Aachen

Aachen, North Rhine-Westphalia, 52074, Germany

Location

MeSH Terms

Conditions

Angina PectorisCoronary Stenosis

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary Disease

Study Officials

  • Michael Becker, MD

    University Hospital, Aachen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2013

First Posted

September 4, 2013

Study Start

June 1, 2011

Primary Completion

May 1, 2016

Study Completion

July 1, 2016

Last Updated

September 23, 2015

Record last verified: 2015-09

Locations